Skip to main
OMDA

OMDA Stock Forecast & Price Target

OMDA Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 27%
Buy 55%
Hold 18%
Sell 0%
Strong Sell 0%

Bulls say

Omada Health is a leader in the digital health industry, with a specialized platform that supports individuals with chronic conditions through personalized care. Their recent partnerships and acquisitions, combined with a strong target gross margin and adjusted EBITDA margins, showcase the company's potential for growth and profitability in the future. Investors can expect a positive impact on the company's stock due to its commitment to delivering measurable outcomes and value for its clients.

Bears say

Omada Health is currently facing significant financial challenges, partly due to the high prevalence and increasing rates of chronic conditions and obesity in the US. The company's current revenue growth and profitability are largely driven by its prevention and weight management programs, with limited contribution from other programs. Moreover, Omada is expected to face further investments in 2026, including AI initiatives and a new GLP-1 care track, which may impact near-term margins. Thus, there are concerns about the company's ability to achieve its long-term targets and maintain high margins in the face of increasing competition and healthcare costs.

OMDA has been analyzed by 11 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 55% recommend Buy, 18% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Omada Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Omada Health Inc (OMDA) Forecast

Analysts have given OMDA a Buy based on their latest research and market trends.

According to 11 analysts, OMDA has a Buy consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21.73, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21.73, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Omada Health Inc (OMDA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.